Sartorius AG Pref SRT3
XETR · Germany · Health Technology
€261.00-0.80 (-0.31%)
Market closed· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
OXB Appoints Joachim Kreuzburg as Independent Non-Executive Director Oxford, UK – 16 October 2026: OXB (LSE: OXB), a global quality and innovation-led cell and gene therapy CDMO, today announces the appointment of Dr Joachim Kreuzburg as an Independent Non-Executive Director, effective on 23 November 2026. Dr Kreuzburg has more than 20 years of public company leadership experience in the global life sciences industry. He was Chair of the Executive Board and Chief Executive Officer of Sartorius A
Boost ROI with modular, customized systems that scale flexibly, cut cleaning and contamination costs, speed fill-finish, and localize sourcing to reduce tariff and supply-chain risks.Dublin, Oct. 14, 2026 (GLOBE NEWSWIRE) -- "Single-Use Assemblies Market Report 2026" has been added to ResearchAndMarkets.com's offering. The global single-use assemblies market is experiencing rapid growth, driven by expanding biopharmaceutical manufacturing, increased investment in life sciences research and devel
Boost ROI with scalable, high-throughput 3D platforms that cut variability and per-sample costs, maximize limited cells, and localize production to offset tariffs.Dublin, Oct. 14, 2026 (GLOBE NEWSWIRE) -- "3D Cell Culture Technologies Market Report 2026" has been added to ResearchAndMarkets.com's offering. The global 3D cell culture technologies market is experiencing rapid expansion, supported by growing pharmaceutical research, increased investment in regenerative medicine, and demand for more
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.